Evidence map›Paper›PMID 41959910›Full record

ArticleFrontiers in oncology2026

Generation of NBS1 knockout in Chinese hamster cells revealed ATR role for radiation and etoposide induced DNA damage in absence of NBS1 proteins.

Gamze Badakul, Junko Maeda, Takamitsu A Kato

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Gamze BadakulDepartment of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, CO, United States.
Junko MaedaDepartment of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, CO, United States.
Takamitsu A KatoDepartment of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, CO, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nijmegen Breakage Syndrome (NBS) is a rare autosomal recessive disorder characterized by chromosomal instability, immunodeficiency, radiosensitivity, and a strong predisposition to lymphoid malignancies. It is caused by mutations in the NBN gene encoding nibrin (NBS1) protein, a core component of the MRE11-RAD50-NBS1 (MRN) complex that senses DNA double-strand breaks (DSBs) and coordinates DNA damage response, including ATM activation. Despite the importance of NBS1, in the Chinese hamster system, which offers significant advantages in radiation biology and toxicology, no mutant lines deficient in the NBS1 gene have been isolated. In this study, we generated two novel NBS1 mutant Chinese hamster cell lines using CRISPR/Cas9, each carrying distinct NBN mutations leading to either null or hypomorphic mutations. These mutants exhibited growth retardation, marked sensitivity to ionizing radiation and various DNA damaging agents and elevated radiation induced chromosomal aberrations, recapitulating key NBS phenotypes. Notably, NBS1 mutant cells displayed pronounced hypersensitivity to ionizing radiation when co-treated with an ATR inhibitor, but not with a DNA-PK inhibitor. The ATR inhibitor also markedly sensitized NBS1 mutants to Etoposide, suggesting that ATR functions as a compensatory pathway in the absence of functional NBS1 during specific types of DNA damage. Collectively, our findings establish valuable NBS1-deficient Chinese hamster cell models that expand understanding of NBS1 function and highlight their utility for investigating DNA repair deficiencies and developing targeted therapeutic approaches for chromosomal instability disorders and cancers with NBS1 mutations.

Indexed as

ATRcell survivalChinese hamsterCRISPR/Cas9NBS1

Identifiers

PMID41959910
PMCPMC13056612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.